nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—NT5E—brown adipose tissue—metabolic syndrome X	0.106	0.258	CbGeAlD
Pentoxifylline—PDE5A—penis—metabolic syndrome X	0.0655	0.159	CbGeAlD
Pentoxifylline—PDE5A—artery—metabolic syndrome X	0.0303	0.0736	CbGeAlD
Pentoxifylline—Emotional distress—Metformin—metabolic syndrome X	0.0274	0.0858	CcSEcCtD
Pentoxifylline—PDE5A—endothelium—metabolic syndrome X	0.0256	0.0622	CbGeAlD
Pentoxifylline—Abdominal bloating—Metformin—metabolic syndrome X	0.0245	0.0766	CcSEcCtD
Pentoxifylline—PDE5A—blood vessel—metabolic syndrome X	0.0236	0.0574	CbGeAlD
Pentoxifylline—Heartburn—Metformin—metabolic syndrome X	0.017	0.053	CcSEcCtD
Pentoxifylline—NT5E—cardiovascular system—metabolic syndrome X	0.0162	0.0394	CbGeAlD
Pentoxifylline—NT5E—kidney—metabolic syndrome X	0.0159	0.0386	CbGeAlD
Pentoxifylline—NT5E—adipose tissue—metabolic syndrome X	0.0143	0.0348	CbGeAlD
Pentoxifylline—ADORA2B—adipose tissue—metabolic syndrome X	0.0123	0.0298	CbGeAlD
Pentoxifylline—ADORA2A—cardiovascular system—metabolic syndrome X	0.0116	0.0281	CbGeAlD
Pentoxifylline—PDE4A—adipose tissue—metabolic syndrome X	0.0109	0.0265	CbGeAlD
Pentoxifylline—PDE5A—cardiovascular system—metabolic syndrome X	0.0105	0.0256	CbGeAlD
Pentoxifylline—Lightheadedness—Metformin—metabolic syndrome X	0.0104	0.0326	CcSEcCtD
Pentoxifylline—NT5E—liver—metabolic syndrome X	0.01	0.0244	CbGeAlD
Pentoxifylline—ADORA1—cardiovascular system—metabolic syndrome X	0.00998	0.0243	CbGeAlD
Pentoxifylline—Ear pain—Metformin—metabolic syndrome X	0.00993	0.031	CcSEcCtD
Pentoxifylline—ADORA1—kidney—metabolic syndrome X	0.00977	0.0237	CbGeAlD
Pentoxifylline—Nasal congestion—Metformin—metabolic syndrome X	0.0093	0.0291	CcSEcCtD
Pentoxifylline—PDE5A—adipose tissue—metabolic syndrome X	0.00929	0.0226	CbGeAlD
Pentoxifylline—ADORA1—adipose tissue—metabolic syndrome X	0.0088	0.0214	CbGeAlD
Pentoxifylline—Abdominal distension—Metformin—metabolic syndrome X	0.00737	0.023	CcSEcCtD
Pentoxifylline—ADORA2A—liver—metabolic syndrome X	0.00715	0.0174	CbGeAlD
Pentoxifylline—Angina pectoris—Metformin—metabolic syndrome X	0.00713	0.0223	CcSEcCtD
Pentoxifylline—Abdominal discomfort—Metformin—metabolic syndrome X	0.00702	0.0219	CcSEcCtD
Pentoxifylline—Infestation NOS—Metformin—metabolic syndrome X	0.00653	0.0204	CcSEcCtD
Pentoxifylline—Infestation—Metformin—metabolic syndrome X	0.00653	0.0204	CcSEcCtD
Pentoxifylline—Drowsiness—Metformin—metabolic syndrome X	0.00653	0.0204	CcSEcCtD
Pentoxifylline—PDE4B—adipose tissue—metabolic syndrome X	0.00651	0.0158	CbGeAlD
Pentoxifylline—Hepatobiliary disease—Metformin—metabolic syndrome X	0.00617	0.0193	CcSEcCtD
Pentoxifylline—Hepatitis—Metformin—metabolic syndrome X	0.00586	0.0183	CcSEcCtD
Pentoxifylline—Flushing—Metformin—metabolic syndrome X	0.00544	0.017	CcSEcCtD
Pentoxifylline—Immune system disorder—Metformin—metabolic syndrome X	0.00529	0.0165	CcSEcCtD
Pentoxifylline—Erythema—Metformin—metabolic syndrome X	0.0051	0.0159	CcSEcCtD
Pentoxifylline—Flatulence—Metformin—metabolic syndrome X	0.00503	0.0157	CcSEcCtD
Pentoxifylline—Dysgeusia—Metformin—metabolic syndrome X	0.00499	0.0156	CcSEcCtD
Pentoxifylline—Muscle spasms—Metformin—metabolic syndrome X	0.0049	0.0153	CcSEcCtD
Pentoxifylline—Vision blurred—Metformin—metabolic syndrome X	0.00481	0.015	CcSEcCtD
Pentoxifylline—Tremor—Metformin—metabolic syndrome X	0.00478	0.0149	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Metformin—metabolic syndrome X	0.00473	0.0148	CcSEcCtD
Pentoxifylline—Malaise—Metformin—metabolic syndrome X	0.0046	0.0144	CcSEcCtD
Pentoxifylline—PDE4B—liver—metabolic syndrome X	0.00457	0.0111	CbGeAlD
Pentoxifylline—Palpitations—Metformin—metabolic syndrome X	0.00451	0.0141	CcSEcCtD
Pentoxifylline—Hypertension—Metformin—metabolic syndrome X	0.0044	0.0138	CcSEcCtD
Pentoxifylline—Chest pain—Metformin—metabolic syndrome X	0.00434	0.0136	CcSEcCtD
Pentoxifylline—Myalgia—Metformin—metabolic syndrome X	0.00434	0.0136	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00431	0.0135	CcSEcCtD
Pentoxifylline—Discomfort—Metformin—metabolic syndrome X	0.00429	0.0134	CcSEcCtD
Pentoxifylline—Oedema—Metformin—metabolic syndrome X	0.00416	0.013	CcSEcCtD
Pentoxifylline—Infection—Metformin—metabolic syndrome X	0.00414	0.0129	CcSEcCtD
Pentoxifylline—Shock—Metformin—metabolic syndrome X	0.0041	0.0128	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Metformin—metabolic syndrome X	0.00408	0.0127	CcSEcCtD
Pentoxifylline—Skin disorder—Metformin—metabolic syndrome X	0.00404	0.0126	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Metformin—metabolic syndrome X	0.00402	0.0126	CcSEcCtD
Pentoxifylline—Anorexia—Metformin—metabolic syndrome X	0.00397	0.0124	CcSEcCtD
Pentoxifylline—Hypotension—Metformin—metabolic syndrome X	0.00389	0.0122	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00379	0.0119	CcSEcCtD
Pentoxifylline—Dyspnoea—Metformin—metabolic syndrome X	0.00371	0.0116	CcSEcCtD
Pentoxifylline—Somnolence—Metformin—metabolic syndrome X	0.0037	0.0116	CcSEcCtD
Pentoxifylline—Dyspepsia—Metformin—metabolic syndrome X	0.00366	0.0115	CcSEcCtD
Pentoxifylline—Decreased appetite—Metformin—metabolic syndrome X	0.00362	0.0113	CcSEcCtD
Pentoxifylline—Constipation—Metformin—metabolic syndrome X	0.00356	0.0111	CcSEcCtD
Pentoxifylline—Feeling abnormal—Metformin—metabolic syndrome X	0.00343	0.0107	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Metformin—metabolic syndrome X	0.0034	0.0106	CcSEcCtD
Pentoxifylline—Urticaria—Metformin—metabolic syndrome X	0.00331	0.0103	CcSEcCtD
Pentoxifylline—Abdominal pain—Metformin—metabolic syndrome X	0.00329	0.0103	CcSEcCtD
Pentoxifylline—Asthenia—Metformin—metabolic syndrome X	0.00299	0.00933	CcSEcCtD
Pentoxifylline—Pruritus—Metformin—metabolic syndrome X	0.00295	0.0092	CcSEcCtD
Pentoxifylline—Diarrhoea—Metformin—metabolic syndrome X	0.00285	0.0089	CcSEcCtD
Pentoxifylline—CYP1A2—liver—metabolic syndrome X	0.00281	0.00682	CbGeAlD
Pentoxifylline—Dizziness—Metformin—metabolic syndrome X	0.00275	0.0086	CcSEcCtD
Pentoxifylline—Vomiting—Metformin—metabolic syndrome X	0.00265	0.00827	CcSEcCtD
Pentoxifylline—Rash—Metformin—metabolic syndrome X	0.00262	0.0082	CcSEcCtD
Pentoxifylline—Dermatitis—Metformin—metabolic syndrome X	0.00262	0.0082	CcSEcCtD
Pentoxifylline—Headache—Metformin—metabolic syndrome X	0.00261	0.00815	CcSEcCtD
Pentoxifylline—Nausea—Metformin—metabolic syndrome X	0.00247	0.00773	CcSEcCtD
Pentoxifylline—ADORA1—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00029	0.00108	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000288	0.00107	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000287	0.00107	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000286	0.00107	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—AGT—metabolic syndrome X	0.000285	0.00106	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000283	0.00105	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—GGT1—metabolic syndrome X	0.000281	0.00105	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CCL5—metabolic syndrome X	0.000281	0.00105	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	0.00028	0.00104	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.00028	0.00104	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RBP4—metabolic syndrome X	0.000279	0.00104	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TRIB3—metabolic syndrome X	0.000279	0.00104	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—ALB—metabolic syndrome X	0.000277	0.00103	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—GHRL—metabolic syndrome X	0.000277	0.00103	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TRIB3—metabolic syndrome X	0.000276	0.00103	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RBP4—metabolic syndrome X	0.000276	0.00103	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—CCL2—metabolic syndrome X	0.000273	0.00102	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—metabolic syndrome X	0.000271	0.00101	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—NOS3—metabolic syndrome X	0.000265	0.000988	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—APOC3—metabolic syndrome X	0.000264	0.000984	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CCL5—metabolic syndrome X	0.000263	0.000979	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HTR2C—metabolic syndrome X	0.000263	0.000978	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CNR1—metabolic syndrome X	0.000262	0.000976	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000262	0.000976	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CCL5—metabolic syndrome X	0.00026	0.000968	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000259	0.000964	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—AGT—metabolic syndrome X	0.000259	0.000963	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—AGT—metabolic syndrome X	0.000259	0.000963	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CYBA—metabolic syndrome X	0.000254	0.000947	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—metabolic syndrome X	0.000253	0.000944	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—metabolic syndrome X	0.000253	0.000944	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—GHRL—metabolic syndrome X	0.000249	0.000927	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HDAC3—metabolic syndrome X	0.000247	0.000922	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—APOC3—metabolic syndrome X	0.000247	0.000921	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—APOC3—metabolic syndrome X	0.000244	0.00091	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PTGS2—metabolic syndrome X	0.000243	0.000904	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—AGT—metabolic syndrome X	0.000242	0.000902	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—AGT—metabolic syndrome X	0.000239	0.000891	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HTR2C—metabolic syndrome X	0.000238	0.000888	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CNR1—metabolic syndrome X	0.000236	0.000878	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—AGT—metabolic syndrome X	0.000235	0.000875	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CYBA—metabolic syndrome X	0.000231	0.00086	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—AKT1—metabolic syndrome X	0.000228	0.000849	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—IL6—metabolic syndrome X	0.000227	0.000844	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—GHRL—metabolic syndrome X	0.000226	0.000842	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	0.000224	0.000833	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000224	0.000833	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HTR2C—metabolic syndrome X	0.000223	0.000831	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—metabolic syndrome X	0.000222	0.000827	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000221	0.000824	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HTR2C—metabolic syndrome X	0.000221	0.000822	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—AGT—metabolic syndrome X	0.00022	0.000819	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—AGT—metabolic syndrome X	0.000217	0.00081	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CYBA—metabolic syndrome X	0.000216	0.000805	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RBP4—metabolic syndrome X	0.000216	0.000803	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TRIB3—metabolic syndrome X	0.000216	0.000803	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CNR1—metabolic syndrome X	0.000214	0.000797	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CYBA—metabolic syndrome X	0.000214	0.000796	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CCL2—metabolic syndrome X	0.000213	0.000793	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	0.000212	0.00079	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—GHRL—metabolic syndrome X	0.000212	0.000788	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—GHRL—metabolic syndrome X	0.000209	0.000779	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—metabolic syndrome X	0.000205	0.000763	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCL5—metabolic syndrome X	0.000203	0.000756	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000202	0.000753	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CNR1—metabolic syndrome X	0.0002	0.000746	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CNR1—metabolic syndrome X	0.000198	0.000738	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CCL2—metabolic syndrome X	0.000193	0.000721	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IGF2—metabolic syndrome X	0.000193	0.000718	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APOC3—metabolic syndrome X	0.000191	0.000711	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—APOB—metabolic syndrome X	0.000187	0.000697	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—AGT—metabolic syndrome X	0.000187	0.000697	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	0.000184	0.000687	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCL5—metabolic syndrome X	0.000183	0.00068	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000182	0.000678	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CCL2—metabolic syndrome X	0.000181	0.000675	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	0.00018	0.000671	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CCL2—metabolic syndrome X	0.000179	0.000667	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—LPL—metabolic syndrome X	0.000179	0.000665	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IGF2—metabolic syndrome X	0.000175	0.000652	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	0.000175	0.00065	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	0.000173	0.000644	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HTR2C—metabolic syndrome X	0.000172	0.000642	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—IL6—metabolic syndrome X	0.000171	0.000636	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—APOB—metabolic syndrome X	0.00017	0.000633	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—AGT—metabolic syndrome X	0.00017	0.000633	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CYBA—metabolic syndrome X	0.000167	0.000622	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCL5—metabolic syndrome X	0.000166	0.000618	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000165	0.000615	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IGF2—metabolic syndrome X	0.000164	0.00061	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GHRL—metabolic syndrome X	0.000163	0.000609	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—LPL—metabolic syndrome X	0.000162	0.000604	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IGF2—metabolic syndrome X	0.000162	0.000603	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	0.000161	0.000598	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—APOB—metabolic syndrome X	0.000159	0.000592	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—AKT1—metabolic syndrome X	0.000158	0.000587	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—APOB—metabolic syndrome X	0.000157	0.000585	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCL5—metabolic syndrome X	0.000155	0.000579	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000155	0.000576	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CNR1—metabolic syndrome X	0.000155	0.000576	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCL5—metabolic syndrome X	0.000153	0.000572	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000153	0.000569	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AGT—metabolic syndrome X	0.000153	0.000569	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—LPL—metabolic syndrome X	0.000152	0.000566	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—LPL—metabolic syndrome X	0.00015	0.000559	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—LEP—metabolic syndrome X	0.00015	0.000558	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—APOE—metabolic syndrome X	0.00015	0.000558	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—APOA1—metabolic syndrome X	0.000148	0.000551	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	0.000143	0.000533	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	0.000142	0.00053	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCL2—metabolic syndrome X	0.00014	0.000521	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—FMO3—metabolic syndrome X	0.00014	0.000521	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AGT—metabolic syndrome X	0.000139	0.000517	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	0.000138	0.000515	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—APOE—metabolic syndrome X	0.000136	0.000506	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—LEP—metabolic syndrome X	0.000136	0.000506	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—APOA1—metabolic syndrome X	0.000134	0.000501	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IRS1—metabolic syndrome X	0.000134	0.000497	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	0.000132	0.000493	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AGT—metabolic syndrome X	0.00013	0.000484	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	0.000128	0.000478	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AGT—metabolic syndrome X	0.000128	0.000478	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—INS—metabolic syndrome X	0.000128	0.000476	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—LEP—metabolic syndrome X	0.000127	0.000474	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—APOE—metabolic syndrome X	0.000127	0.000474	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IGF2—metabolic syndrome X	0.000126	0.000471	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCL2—metabolic syndrome X	0.000126	0.000469	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—APOA1—metabolic syndrome X	0.000126	0.000469	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—LEP—metabolic syndrome X	0.000126	0.000469	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—APOE—metabolic syndrome X	0.000126	0.000469	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.000125	0.000465	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MLXIPL—metabolic syndrome X	0.000125	0.000464	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—EPHX2—metabolic syndrome X	0.000125	0.000464	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—APOA1—metabolic syndrome X	0.000124	0.000463	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IGF1—metabolic syndrome X	0.000124	0.000461	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APOB—metabolic syndrome X	0.000123	0.000457	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—AKT1—metabolic syndrome X	0.000122	0.000454	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IRS1—metabolic syndrome X	0.000121	0.000452	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCL5—metabolic syndrome X	0.00012	0.000447	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000119	0.000445	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000117	0.000438	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—LPL—metabolic syndrome X	0.000117	0.000437	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—G6PC2—metabolic syndrome X	0.000117	0.000436	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—INS—metabolic syndrome X	0.000116	0.000433	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCL2—metabolic syndrome X	0.000114	0.000426	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IRS1—metabolic syndrome X	0.000114	0.000423	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IGF1—metabolic syndrome X	0.000112	0.000418	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IRS1—metabolic syndrome X	0.000112	0.000418	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NOS3—metabolic syndrome X	0.000112	0.000418	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.000111	0.000415	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—INS—metabolic syndrome X	0.000109	0.000405	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	0.000108	0.000402	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—INS—metabolic syndrome X	0.000107	0.0004	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCL2—metabolic syndrome X	0.000107	0.000399	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000107	0.000397	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCL2—metabolic syndrome X	0.000106	0.000394	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IGF1—metabolic syndrome X	0.000105	0.000392	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IGF1—metabolic syndrome X	0.000104	0.000387	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NOS3—metabolic syndrome X	0.000102	0.000379	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AGT—metabolic syndrome X	0.0001	0.000374	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SERPINE1—metabolic syndrome X	9.99e-05	0.000372	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—FABP4—metabolic syndrome X	9.96e-05	0.000371	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SERPINE1—metabolic syndrome X	9.87e-05	0.000368	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—LEP—metabolic syndrome X	9.83e-05	0.000366	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APOE—metabolic syndrome X	9.83e-05	0.000366	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APOA1—metabolic syndrome X	9.72e-05	0.000362	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—AKT1—metabolic syndrome X	9.61e-05	0.000358	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NOS3—metabolic syndrome X	9.54e-05	0.000355	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL6—metabolic syndrome X	9.46e-05	0.000352	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HSD11B1—metabolic syndrome X	9.44e-05	0.000352	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NOS3—metabolic syndrome X	9.42e-05	0.000351	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	9.15e-05	0.000341	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	8.9e-05	0.000332	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IRS1—metabolic syndrome X	8.77e-05	0.000327	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	8.74e-05	0.000326	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—AKT1—metabolic syndrome X	8.73e-05	0.000325	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.73e-05	0.000325	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL6—metabolic syndrome X	8.59e-05	0.00032	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—G6PD—metabolic syndrome X	8.42e-05	0.000313	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—INS—metabolic syndrome X	8.4e-05	0.000313	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	8.3e-05	0.000309	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCL2—metabolic syndrome X	8.26e-05	0.000308	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HDAC3—metabolic syndrome X	8.21e-05	0.000306	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—AKT1—metabolic syndrome X	8.17e-05	0.000304	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IGF1—metabolic syndrome X	8.12e-05	0.000303	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—AKT1—metabolic syndrome X	8.08e-05	0.000301	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL6—metabolic syndrome X	8.04e-05	0.0003	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GCKR—metabolic syndrome X	8.03e-05	0.000299	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—LPA—metabolic syndrome X	8.03e-05	0.000299	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL6—metabolic syndrome X	7.95e-05	0.000296	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—AKT1—metabolic syndrome X	7.93e-05	0.000295	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PLA2G6—metabolic syndrome X	7.78e-05	0.00029	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	7.72e-05	0.000288	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	7.71e-05	0.000287	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—APOA5—metabolic syndrome X	7.7e-05	0.000287	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	7.48e-05	0.000278	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—AKT1—metabolic syndrome X	7.42e-05	0.000276	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TGFB1—metabolic syndrome X	7.42e-05	0.000276	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NOS3—metabolic syndrome X	7.36e-05	0.000274	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—AKT1—metabolic syndrome X	7.33e-05	0.000273	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	7.33e-05	0.000273	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	7.24e-05	0.00027	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TRIB3—metabolic syndrome X	7.16e-05	0.000267	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TGFB1—metabolic syndrome X	6.73e-05	0.000251	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NAMPT—metabolic syndrome X	6.42e-05	0.000239	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	6.38e-05	0.000238	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—LIPC—metabolic syndrome X	6.38e-05	0.000238	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GCK—metabolic syndrome X	6.38e-05	0.000238	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—APOC3—metabolic syndrome X	6.34e-05	0.000236	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	6.31e-05	0.000235	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TGFB1—metabolic syndrome X	6.31e-05	0.000235	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TGFB1—metabolic syndrome X	6.23e-05	0.000232	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL6—metabolic syndrome X	6.21e-05	0.000231	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CETP—metabolic syndrome X	6.15e-05	0.000229	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	5.89e-05	0.000219	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	5.74e-05	0.000214	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—AKT1—metabolic syndrome X	5.73e-05	0.000213	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	5.72e-05	0.000213	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL6—metabolic syndrome X	5.59e-05	0.000208	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	5.56e-05	0.000207	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GOT2—metabolic syndrome X	5.56e-05	0.000207	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AKT1—metabolic syndrome X	5.16e-05	0.000192	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL6—metabolic syndrome X	5.07e-05	0.000189	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	5.02e-05	0.000187	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	4.96e-05	0.000185	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	4.96e-05	0.000185	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TGFB1—metabolic syndrome X	4.87e-05	0.000181	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GOT1—metabolic syndrome X	4.8e-05	0.000179	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GGT1—metabolic syndrome X	4.8e-05	0.000179	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL6—metabolic syndrome X	4.75e-05	0.000177	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6—metabolic syndrome X	4.7e-05	0.000175	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AKT1—metabolic syndrome X	4.68e-05	0.000174	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AKT1—metabolic syndrome X	4.38e-05	0.000163	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AKT1—metabolic syndrome X	4.33e-05	0.000161	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—APOB—metabolic syndrome X	4.08e-05	0.000152	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	3.96e-05	0.000148	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—LPL—metabolic syndrome X	3.89e-05	0.000145	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CD36—metabolic syndrome X	3.7e-05	0.000138	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6—metabolic syndrome X	3.67e-05	0.000137	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PPARA—metabolic syndrome X	3.44e-05	0.000128	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKT1—metabolic syndrome X	3.38e-05	0.000126	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AGT—metabolic syndrome X	3.33e-05	0.000124	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—APOE—metabolic syndrome X	3.26e-05	0.000122	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—APOA1—metabolic syndrome X	3.22e-05	0.00012	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PPARG—metabolic syndrome X	2.84e-05	0.000106	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—INS—metabolic syndrome X	2.79e-05	0.000104	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALB—metabolic syndrome X	2.56e-05	9.52e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NOS3—metabolic syndrome X	2.44e-05	9.1e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	2.24e-05	8.33e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AKT1—metabolic syndrome X	1.12e-05	4.18e-05	CbGpPWpGaD
